YK-029A,Pemetrexed,carboplatin,Cisplatin
Suzhou Pharmaceutical Technology
['nsclc', 'sclc']
#asco23 poster discussion #nsclc
phase i/ii trial of yk-029a in #egfr exon20, or rare mutations impressive efficacy seen t/t naive ex20 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl